IMPACT OF ABATACEPT ON DISEASE ACTIVITY AND FUNCTIONAL STATUS IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS

被引：0
|
作者：
Kanonirova, M. A. [1 ]
Lukina, G. [1 ]
Sigidin, Y. [1 ]
Aronova, E. [1 ]
Glukhova, S. [2 ]
Luchihina, E. [3 ]
Karateev, D. [3 ]
Nasonov, E. [4 ]
机构：
[1] Dept Early Arthritis, Lab Clin Pharmacol, Moscow, Russia
[2] Lab Informat Technol, Moscow, Russia
[3] Dept Early Arthritis, Moscow, Russia
[4] Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5945
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0360
引用
下载
收藏
页码：1026 / 1026
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF ABATACEPT INFLUENCE ON DISEASE ACTIVITY AND FUNCTIONAL STATUS IN PATIENTS WITH DIFFERENT STAGES OF RHEUMATOID ARTHRITIS
    Borisova, Maria A.
    Lukina, Galina V.
    Sigidin, Yakov A.
    Sergeevna, Evgeniya A.
    Glukhova, Svetlana I.
    Luchihina, Elena L.
    Karateev, Dmitriy E.
    Nasonov, Evgeniy L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A61 - A61
  • [2] RESULTS OF ABATACEPT TREATMENT IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS
    Kanonirova, M. A.
    Lukina, G. V.
    Sigidin, Y. A.
    Aronova, E. S.
    Glukhova, S. I.
    Luchihina, E. L.
    Karateev, D. E.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A59 - +
  • [3] Effect of education on disease activity and functional status in rheumatoid arthritis patients
    Gamal, Sherif M.
    Eleishi, Hatem H.
    Moghazy, Abdelkawy
    El-Garf, Kamal
    Eissa, Mervat
    Sobhy, Nesreen
    Medhat, Basma M.
    El-Ghobashy, Nehal
    El-Zorkany, Bassel
    EGYPTIAN RHEUMATOLOGIST, 2021, 43 (01): : 7 - 11
  • [4] Minimal disease activity state for patients with rheumatoid arthritis treated with abatacept
    Wells, G. A.
    Boers, M.
    Li, T.
    Tugwell, P.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1181 - 1181
  • [5] Minimal disease activity state for patients with rheumatoid arthritis treated with abatacept
    Wells, G. A.
    Boers, M.
    Li, T.
    Tugwell, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 341 - 341
  • [6] Global Functional Status in Rheumatoid Arthritis: Disease Duration and Patient Age
    J. E. Fonseca
    H. Canha˜o
    J. C. Teixeira da Costa
    J. A. Pereira da Silva
    M. Viana Queiroz
    Clinical Rheumatology, 2002, 21 : 32 - 34
  • [7] Global functional status in rheumatoid arthritis: Disease duration and patient age
    Fonseca, JE
    Canhao, H
    da Costa, JCT
    da Silva, JAP
    Queiroz, MV
    CLINICAL RHEUMATOLOGY, 2002, 21 (01) : 32 - 34
  • [8] STATUS OF DISEASE ACTIVITY, FUNCTIONAL IMPAIRMENT AND TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND COMORBIDITIES
    Tanaka, E.
    Inoue, E.
    Yamaguchi, R.
    Shimizu, Y.
    Sugimoto, N.
    Hoshi, D.
    Shidara, K.
    Sato, E.
    Seto, Y.
    Nakajima, A.
    Momohara, S.
    Taniguchi, A.
    Yamanaka, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 446 - 446
  • [9] The impact of abatacept treatment on the vasculature in patients with rheumatoid arthritis
    Sandoo, A.
    Kitas, G. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : 589 - 589
  • [10] Is Disease Duration an Independent Predictor of Treatment Response Among Patients with Rheumatoid Arthritis Initiating Abatacept?
    Harrold, Leslie
    Gandhi, K. K.
    Litman, H.
    Kelly, S.
    Li, Y. F.
    Alemao, E.
    Deveikis, S.
    Kremer, J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345